VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
PDF
  • The predictive value of the aCL and anti-[beta]2GPI at the time of acute deep vein thrombosis - a two-year prospective study [Elektronski vir]
    Perdan-Pirkmajer, Katja ...
    Antiphospholipid syndrome (APS) is an important cause of deep vein thrombosis (DVT). According to current APS classification criteria, APS cannot be confirmed until 24 weeks after DVT. This time ... frame results in frequent discontinuation of anticoagulant treatment before APS is diagnosed. Therefore, the aim of our study was to evaluate the potential predictive value of anticardiolipin (aCL) and anti-[beta]2glycoprotein I (anti-[beta]2GPI) before discontinuation of anticoagulation therapy. Patients with newly diagnosed DVT were included into a 24-month prospective study. All patients received anticoagulant therapy. aCL and anti-[beta]2GPI were determined at inclusion and every four weeks for the first 24 weeks and then one and two years after inclusion. APS was confirmed in 24/221 (10.9%) patients. At the time of acute DVT 20/24 (83.3%), APS patients had positive aCL and/or anti-[beta]2GPI. Two patients had low aCL levels and two were negative at the time of acute DVT but later met APS criteria due to lupus anticoagulant (LA). Our data indicate that negative aCL and/or anti-[beta]2GPI at the time of acute DVT make further aPL testing unnecessary; however, LA should be determined after discontinuation of anticoagulant therapy. Positive aCL and/or anti-[beta]2GPI at the time of acute DVT have a strong positive predictive value for APS and may support therapeutic decisions.
    Vir: Biomedicines [Elektronski vir]. - ISSN 2227-9059 (Vol. 9, iss. 8, 2021, str. 1-10)
    Vrsta gradiva - e-članek ; neleposlovje za odrasle
    Leto - 2021
    Jezik - angleški
    COBISS.SI-ID - 72525315

    Povezava(-e):

    https://www.mdpi.com/2227-9059/9/8/901
    Repozitorij Univerze v Ljubljani – RUL
    DOI

Vnos na polico